Skip to main content
Call
Denialsaka Denied Claim, Medical Claim Denial

What is Claim Denial? Definition, Formula, and Benchmark

Reviewed by QuickIntell RCM Editorial Team · Last reviewed

Updated

Definition

A claim denial is a payer's decision to refuse payment on a claim that was accepted for adjudication, communicated via a CARC on the remittance advice. Denials are distinct from rejections (which never reach adjudication) and require either corrected resubmission, additional documentation, or formal appeal to recover the payment.

Overview

A claim denial is a payer's post-adjudication decision not to pay a claim or a specific service line, communicated back to the provider through the 835 electronic remittance advice as a CARC (claim adjustment reason code) and optional RARC (remittance advice remark code). Critically, a denial is different from a rejection. A rejection occurs before adjudication when the claim fails clearinghouse or payer front-end edits — never reaches the adjudicator. A denial occurs when the claim was accepted for adjudication but the adjudicator decided not to pay.

Denials fall into two broad families. Hard denials are non-recoverable — timely filing exceeded, service not covered under the patient's benefit plan, member not eligible on date of service. Soft denials are recoverable through corrective action — missing information, prior authorization obtainable retroactively, coding errors correctable on resubmission. The operational task is to triage each denial into hard vs soft quickly and route soft denials to the right work queue for recovery.

Common denial categories include medical necessity (service not supported by the diagnosis per payer LCD/medical policy), authorization-related (no PA on file, PA denied, or retroactive PA needed), coding issues (invalid CPT/HCPCS, modifier required, NCCI edit failure), eligibility (member not enrolled, coverage terminated, wrong payer), coordination-of-benefits (primary payer should have been billed first), duplicate (claim already submitted), and timely filing (submission beyond payer's filing window).

Recovery workflows vary by denial type. Medical-necessity denials usually require a clinical documentation review and a formal appeal with supporting records. Authorization denials may be recoverable via retro-authorization request to the payer or, in some states, via peer-to-peer review. Coding-issue denials typically resubmit with corrections — different modifier, added documentation, corrected code. Eligibility denials require rebilling to the correct payer or patient statement routing. Each type has its own time budget, appeal level structure, and documentation requirements.

Denial analytics at mature organizations look beyond individual claims to trend patterns. A spike in CARC 197 (authorization absent) for a specific specialty signals an authorization workflow gap. A rising denominator of CARC 45 (write-off per fee-schedule) indicates contract-rate issues not operational denials. A surge in CARC 252 (an attachment is required) may reflect an 837 mapping change. The path from raw 835 data to actionable denial reports is a core RCM analytics capability.

Denial-management teams that treat Claim Denial as a single root cause almost always out-perform teams that work denials claim-by-claim. The editorial convention on this site is to pair every Claim Denial reference with its upstream prevention checklist so the same pattern appears on fewer future remits, not just on a cleaner first-level appeal. Claim Denial interactions with denial rate and claim rejection are the most common source of re-worked claims in our reviewers' experience: the CARC you pay attention to on the first pass is frequently not the one that actually drives the rework cycle on the second pass.

Industry benchmark

HFMA MAP Keys denial rate: <5% healthy, <3% best-in-class. Industry surveys show 50–65% of denials are preventable and 60–75% of denied dollars are recoverable with proper appeals work. Roughly 40% of denials are never worked at all, leaving recoverable revenue on the table.

Worked example

A 30-provider practice receives 850 denials in a month against 14,000 submitted claims, a denial rate of 6.1%. Analysis: 38% medical necessity, 22% authorization, 19% coding, 12% eligibility, 9% other. The top two categories represent 60% of denial volume. A targeted eligibility fix at registration and an authorization workflow redesign reduce denial rate to 4.2% three months later, recovering ~$180K/month in previously lost revenue.

Frequently asked questions — Claim Denial

What's the difference between denial and rejection?

A rejection occurs before adjudication — the claim fails a clearinghouse or payer front-end edit and never reaches the adjudicator. A denial occurs after adjudication — the claim was accepted for processing but the adjudicator decided not to pay. Operationally they're worked by the same team but require different remediation paths.

What percentage of denials are recoverable?

Industry estimates: 60–75% of denied dollars are recoverable with proper appeals work. Medical necessity and authorization denials typically have the highest recovery rates when timely appealed. Hard denials (timely filing exceeded, non-covered service) are generally not recoverable.

How should denials be categorized for analytics?

By CARC + RARC for root-cause attribution, by payer, by specialty/provider, by denial reason family (medical necessity, authorization, coding, eligibility, COB, duplicate, timely filing), and by work queue assignment. Multidimensional views surface actionable patterns more reliably than single-dimension summaries.

Should every denial be appealed?

No. Appeals require biller time, which has a cost. A triage step decides: is the denial recoverable, is the dollar value above a cost-of-pursuit threshold, is documentation available to support appeal. Many organizations set a minimum-dollar threshold (e.g., $25–50) below which denials are written off rather than appealed.

Disclaimer

This glossary entry is operational reference for revenue-cycle and medical-billing professionals. It is not legal, clinical, or contractual advice. Industry benchmarks cite named public sources where available; always verify against the current guidance from the authority body before relying on a number in a contract, policy, or compliance filing.